These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 12884191
1. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4. Wali MH, Heydtmann M, Harrison RF, Gunson BK, Mutimer DJ. Liver Transpl; 2003 Aug; 9(8):796-804. PubMed ID: 12884191 [Abstract] [Full Text] [Related]
2. Long-term outcome of hepatitis C infection after liver transplantation. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R. N Engl J Med; 1996 Mar 28; 334(13):815-20. PubMed ID: 8596547 [Abstract] [Full Text] [Related]
3. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Prieto M, Berenguer M, Rayón JM, Córdoba J, Argüello L, Carrasco D, García-Herola A, Olaso V, De Juan M, Gobernado M, Mir J, Berenguer J. Hepatology; 1999 Jan 28; 29(1):250-6. PubMed ID: 9862874 [Abstract] [Full Text] [Related]
4. Long-term outcome of hepatitis C virus infection after liver transplantation. Böker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, Oldhaver K, Bode U, Pichlmayr R, Manns MP. Hepatology; 1997 Jan 28; 25(1):203-10. PubMed ID: 8985291 [Abstract] [Full Text] [Related]
5. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds P, Roberts JP, Lake JR, Ascher NL, Wright TL. Hepatology; 1996 Nov 28; 24(5):1041-6. PubMed ID: 8903372 [Abstract] [Full Text] [Related]
6. Histological and clinical outcome after liver transplantation for hepatitis C. Shuhart MC, Bronner MP, Gretch DR, Thomassen LV, Wartelle CF, Tateyama H, Emerson SS, Perkins JD, Carithers RL. Hepatology; 1997 Dec 28; 26(6):1646-52. PubMed ID: 9398011 [Abstract] [Full Text] [Related]
7. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern? Berenguer M, Aguilera V, Prieto M, Carrasco D, Rayón M, San Juan F, Landaverde C, Mir J, Berenguer J. Liver Transpl; 2003 Nov 28; 9(11):1152-8. PubMed ID: 14586875 [Abstract] [Full Text] [Related]
8. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation. Sugo H, Balderson GA, Crawford DH, Fawcett J, Lynch SV, Strong RW, Futagawa S. Surg Today; 2003 Nov 28; 33(6):421-5. PubMed ID: 12768367 [Abstract] [Full Text] [Related]
9. Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution. Zekry A, Whiting P, Crawford DH, Angus PW, Jeffrey GP, Padbury RT, Gane EJ, McCaughan GW, Australian and New Zealand Liver Transplant Clinical Study Group. Liver Transpl; 2003 Apr 28; 9(4):339-47. PubMed ID: 12682883 [Abstract] [Full Text] [Related]
10. Predictors of patient and graft survival following liver transplantation for hepatitis C. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, Detre K, Hoofnagle J. Hepatology; 1998 Sep 28; 28(3):823-30. PubMed ID: 9731579 [Abstract] [Full Text] [Related]
11. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection. Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Cabrera R, Shuster JJ, Theriaque D, Reed AI, Hemming AW, Liu C, Crawford JM, Nelson DR. Liver Transpl; 2004 Oct 28; 10(10):1240-7. PubMed ID: 15376304 [Abstract] [Full Text] [Related]
12. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis. Briceño J, Ciria R, Pleguezuelo M, de la Mata M, Muntané J, Naranjo A, Sánchez-Hidalgo J, Marchal T, Rufián S, López-Cillero P. Liver Transpl; 2009 Jan 28; 15(1):37-48. PubMed ID: 19109846 [Abstract] [Full Text] [Related]
13. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F. Liver Transpl; 2009 Apr 28; 15(4):390-9. PubMed ID: 19326408 [Abstract] [Full Text] [Related]
14. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients. Takada Y, Haga H, Ito T, Nabeshima M, Ogawa K, Kasahara M, Oike F, Ueda M, Egawa H, Tanaka K. Transplantation; 2006 Feb 15; 81(3):350-4. PubMed ID: 16477219 [Abstract] [Full Text] [Related]
15. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study. Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G. Liver Transpl; 2007 May 15; 13(5):733-40. PubMed ID: 17370330 [Abstract] [Full Text] [Related]
16. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR. Liver Transpl; 2002 Apr 15; 8(4):362-9. PubMed ID: 11965581 [Abstract] [Full Text] [Related]
17. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Berenguer M, Prieto M, San Juan F, Rayón JM, Martinez F, Carrasco D, Moya A, Orbis F, Mir J, Berenguer J. Hepatology; 2002 Jul 15; 36(1):202-10. PubMed ID: 12085366 [Abstract] [Full Text] [Related]
18. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation. Chopra KB, Demetris AJ, Blakolmer K, Dvorchik I, Laskus T, Wang LF, Araya VR, Dodson F, Fung JJ, Rakela J, Vargas HE. Transplantation; 2003 Nov 27; 76(10):1487-91. PubMed ID: 14657691 [Abstract] [Full Text] [Related]
19. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation. Botha JF, Thompson E, Gilroy R, Grant WJ, Mukherjee S, Lyden ER, Fox IJ, Sudan DL, Shaw BW, Langnas AN. Liver Int; 2007 Aug 27; 27(6):758-63. PubMed ID: 17617118 [Abstract] [Full Text] [Related]
20. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center. Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J. Transplant Proc; 2009 Apr 27; 41(3):1041-3. PubMed ID: 19376421 [Abstract] [Full Text] [Related] Page: [Next] [New Search]